» Authors » Jun-Ichi Akahira

Jun-Ichi Akahira

Explore the profile of Jun-Ichi Akahira including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 67
Citations 1258
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sugawara T, Saito H, Hirasawa D, Akahira J, Chonan A
J Can Assoc Gastroenterol . 2023 Dec; 6(6):197-198. PMID: 38106481
No abstract available.
2.
Saito H, Tanaka I, Akahira J, Endo M, Igarashi K, Okuzono T, et al.
Clin J Gastroenterol . 2022 Nov; 16(2):130-135. PMID: 36370153
Esophageal cancer after endoscopic treatment may recur depending on the risk. We present a case of a rare T1b esophageal cancer after endoscopic treatment plus chemoradiotherapy (CRT) that recurred with...
3.
Saito H, Ono K, Akahira J
Clin Gastroenterol Hepatol . 2021 Jan; 20(3):A16. PMID: 33418134
No abstract available.
4.
Saito H, Nishikawa Y, Akahira J, Yamaoka H, Okuzono T, Sawano T, et al.
J Med Case Rep . 2019 Mar; 13(1):61. PMID: 30871625
Background: Secondary aortoenteric fistula is a rare but fatal complication after reconstructive surgery for an aortic aneurysm characterized by abdominal pain, fever, hematochezia, and hematemesis, and the mortality rate is...
5.
Nakamura Y, Fujishima F, Hui X, Felizola S, Shibahara Y, Akahira J, et al.
Endocr Res . 2014 May; 40(1):8-13. PMID: 24832628
Androstenedione is a common precursor of sex steroids produced and secreted in the human adrenal gland and produced by 3β-hydroxysteroid dehydrogenase (3βHSD), 17β-hydroxylase/17,20-lyase (CYP17) and cytochrome b5 (CYB5A). 3βHSD is...
6.
Suzuki F, Nagase S, Suzuki K, Oba E, Hiroki E, Matsuda Y, et al.
Tohoku J Exp Med . 2013 Nov; 231(3):193-9. PMID: 24201220
Uterine papillary serous carcinoma (UPSC) morphologically resembles ovarian serous carcinoma and is categorized as a type II endometrial cancer. UPSC comprises about 10% of all types of endometrial cancer and...
7.
Yue X, Utsunomiya H, Akahira J, Suzuki F, Ito K, Nagase S, et al.
Oncol Lett . 2013 Feb; 5(3):835-839. PMID: 23443531
We analyzed the expression of the steroid and xenobiotic receptor (SXR) in human uterine sarcomas and evaluated its clinical significance. Forty-seven cases with archival specimens were examined for SXR expression...
8.
Shibahara Y, Miki Y, Onodera Y, Hata S, Sm Chan M, Yiu C, et al.
J Pathol . 2012 Mar; 227(3):357-66. PMID: 22407818
Aromatase inhibitors (AIs) are considered the gold standard of endocrine therapy for oestrogen receptor-positive postmenopausal breast cancer patients. AI treatment was reported to result in marked alterations of genetic profiles...
9.
Iida S, Miki Y, Ono K, Akahira J, Nakamura Y, Suzuki T, et al.
Mol Cell Endocrinol . 2011 Dec; 350(1):99-106. PMID: 22178087
Mammalian target of rapamycin (mTOR) inhibitors have been clinically used as anticancer agents in several types of human malignancies including neuroendocrine tumor (NET) but the development of clinical resistances or...
10.
Hiroki E, Suzuki F, Akahira J, Nagase S, Ito K, Sugawara J, et al.
Int J Cancer . 2011 Nov; 131(4):E395-404. PMID: 22052540
Endometrial serous adenocarcinoma (ESC) is aggressive and carries a poor prognosis. p53 is frequently mutated in ESC. microRNAs (miRNAs) are a direct p53 target and have been implicated in cancer...